Comunicación corta
Bevacizumab intravítreo como tratamiento de las telangiectasias yuxtafoveales idiopáticas tipo i
Intravitreal bevacizumab in the treatment of idiopathic juxtafoveal telangiectasis type i
Leído
1493
Vecesse ha leído el artículo
313
Total PDF
1180
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 12 | 1 | 0 | 1 |
| 2023 5 | 2 | 1 | 3 |
| 2023 3 | 3 | 0 | 3 |
| 2020 1 | 2 | 2 | 4 |
| 2020 4 | 1 | 2 | 3 |
| 2018 2 | 30 | 0 | 30 |
| 2018 1 | 40 | 0 | 40 |
| 2017 12 | 37 | 2 | 39 |
| 2017 11 | 25 | 2 | 27 |
| 2017 10 | 24 | 2 | 26 |
| 2017 9 | 20 | 3 | 23 |
| 2017 8 | 22 | 5 | 27 |
| 2017 7 | 26 | 1 | 27 |
| 2017 6 | 18 | 15 | 33 |
| 2017 5 | 23 | 6 | 29 |
| 2017 4 | 19 | 17 | 36 |
| 2017 3 | 26 | 18 | 44 |
| 2017 2 | 19 | 8 | 27 |
| 2016 1 | 30 | 2 | 32 |
| 2016 12 | 39 | 6 | 45 |
| 2016 11 | 28 | 6 | 34 |
| 2016 10 | 61 | 9 | 70 |
| 2016 9 | 59 | 9 | 68 |
| 2016 8 | 51 | 13 | 64 |
| 2016 7 | 30 | 1 | 31 |
| 2016 6 | 45 | 13 | 58 |
| 2016 5 | 43 | 9 | 52 |
| 2016 4 | 38 | 23 | 61 |
| 2016 3 | 43 | 9 | 52 |
| 2016 2 | 28 | 9 | 37 |
| 2015 1 | 27 | 12 | 39 |
| 2015 12 | 24 | 11 | 35 |
| 2015 11 | 24 | 14 | 38 |
| 2015 10 | 49 | 12 | 61 |
| 2015 9 | 35 | 8 | 43 |
| 2015 8 | 34 | 7 | 41 |
| 2015 7 | 19 | 9 | 28 |
| 2015 6 | 0 | 1 | 1 |
| 2015 5 | 27 | 5 | 32 |
| 2015 4 | 23 | 14 | 37 |
| 2015 3 | 34 | 9 | 43 |
| 2015 2 | 12 | 3 | 15 |
| 2015 1 | 29 | 11 | 40 |
| 2014 12 | 4 | 1 | 5 |
| 2014 10 | 1 | 0 | 1 |
| 2014 9 | 0 | 1 | 1 |
| 2014 8 | 0 | 1 | 1 |
| 2014 7 | 5 | 1 | 6 |
Mostrar todo
